<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>53(2)</volume><submitter>De Simone M</submitter><funding>Genentech</funding><pubmed_abstract>This study examined nine prominent commercially available single-cell RNA sequencing (scRNA-seq) kits across four technology groups. Each kit was characterized using peripheral blood mononuclear cells (PBMCs) from a single donor, which enabled consistent assessment of factors such as analytical performance, protocol duration and cost. The Chromium Fixed RNA Profiling kit from 10× Genomics, with its probe-based RNA detection method, demonstrated the best overall performance. The Rhapsody WTA kit from Becton Dickinson exhibited a balance between performance and cost. Importantly, we introduce the read utilization metric, which differentiates scRNA-seq kits based on the efficiency of converting sequencing reads into usable counts. Thus, read utilization is an important feature that substantia</pubmed_abstract><journal>Nucleic acids research</journal><pagination>gkae1186</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11754665</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A comprehensive analysis framework for evaluating commercial single-cell RNA sequencing technologies.</pubmed_title><pmcid>PMC11754665</pmcid><pubmed_authors>Darmanis S</pubmed_authors><pubmed_authors>Au-Yeung A</pubmed_authors><pubmed_authors>Shi M</pubmed_authors><pubmed_authors>Hoover J</pubmed_authors><pubmed_authors>Menon H</pubmed_authors><pubmed_authors>Vaidya S</pubmed_authors><pubmed_authors>Liang Y</pubmed_authors><pubmed_authors>Wu B</pubmed_authors><pubmed_authors>Xavier-Magalhaes A</pubmed_authors><pubmed_authors>Bennett HM</pubmed_authors><pubmed_authors>Chen C</pubmed_authors><pubmed_authors>Lear S</pubmed_authors><pubmed_authors>Lau J</pubmed_authors><pubmed_authors>Kurdoglu A</pubmed_authors><pubmed_authors>O'Gorman WE</pubmed_authors><pubmed_authors>Lund JM</pubmed_authors><pubmed_authors>Le D</pubmed_authors><pubmed_authors>De Simone M</pubmed_authors><pubmed_authors>Modrusan Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>A comprehensive analysis framework for evaluating commercial single-cell RNA sequencing technologies.</name><description>This study examined nine prominent commercially available single-cell RNA sequencing (scRNA-seq) kits across four technology groups. Each kit was characterized using peripheral blood mononuclear cells (PBMCs) from a single donor, which enabled consistent assessment of factors such as analytical performance, protocol duration and cost. The Chromium Fixed RNA Profiling kit from 10× Genomics, with its probe-based RNA detection method, demonstrated the best overall performance. The Rhapsody WTA kit from Becton Dickinson exhibited a balance between performance and cost. Importantly, we introduce the read utilization metric, which differentiates scRNA-seq kits based on the efficiency of converting sequencing reads into usable counts. Thus, read utilization is an important feature that substantia</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-05T10:18:47.04Z</modification><creation>2025-04-05T10:18:47.04Z</creation></dates><accession>S-EPMC11754665</accession><cross_references><pubmed>39675380</pubmed><doi>10.1093/nar/gkae1186</doi></cross_references></HashMap>